ImmunologybioRxivPreprint
Splicing inhibition enhances the antitumor immune response through increased tumor antigen presentation and altered MHC-I immunopeptidome
Alison Pierson, Romain Darrigrand, Marine Rouillon…·Sébastien Apcher
This study shows that splicing inhibition with IP2 enhances antitumor immunity by increasing antigen presentation and altering MHC-I immunopeptidomes.
DOI 10.1101/512681